Enter assignee name

EPO Patents = 5

Trademarks = 1

Forward Citations = 58

Loading Chart...

4 inventors (with patents filed for the assignee):

Peter Ruppersberg (12 out of 30 patents)

Philip Haeusser (3 out of 9 patents)

Peter Jacobs (1 out of 8 patents)

4. David Emanuel Lukŝic (1 out of 3 patents)

5. David Emanuel Luksic (0 patent)

6. Lukas Tenbrink (0 patent)

7. Kostiantyn Serhiyovich Ahapov (2 patents)

8. Melissa Huang Szu-Min Kong (2 patents)

12 patents: Sort by Forward Citations

1. 11839445 - Systems, devices, components and methods for detecting the locations of sources of cardiac rhythm disorders in a patient's heart (2023-12-12),

2. 11672465 - Methods, systems, devices, and components for visualizing electrographic flow (EGF) (2023-06-13),

3. 11523762 - Electrophysiological mapping catheter (2022-12-13),

4. 11484239 - Systems, devices, components and methods for detecting the locations of sources of cardiac rhythm disorders in a patient's heart (2022-11-01),

5. 11471114 - Medical system for mapping of action potential data (2022-10-18),

6. 11389102 - Systems, devices, components and methods for detecting the locations of sources of cardiac rhythm disorders in a patient's heart (2022-07-19),

7. 10980418 - Systems, devices, components and methods for detecting the locations of sources of cardiac rhythm disorders in a patient's heart (2021-04-20),

8. 10888391 - Optical force sensing assembly for an elongated medical device (2021-01-12),

9. 10888236 - System for analyzing electrophysiological data and method for analyzing electrophysiological data (2021-01-12),

10. 10813590 - Electrophysiological mapping catheter (2020-10-27),

11. 10201277 - Systems, devices, components and methods for detecting the locations of sources of cardiac rhythm disorders in a patient's heart (2019-02-12),

12. 10143374 - Systems, devices, components and methods for detecting the locations of sources of cardiac rhythm disorders in a patient's heart (2018-12-04),

Ablacon Inc. is a medical technology company that focuses on developing innovative solutions for the treatment of cardiac arrhythmias. Our cutting-edge technologies and therapies are designed to provide physicians with real-time visualization and mapping systems, allowing for more precise diagnosis and treatment of complex cardiac ablations. With a passion for improving patient outcomes, we strive to revolutionize the field of electrophysiology through our state-of-the-art products and continuous research and development.

This text is generated by artificial intelligence and may not be accurate.